Evidence base and patients' perspective - World Journal of ...

Qiao CX et al . Quality of life with hepatocellular carcinoma
Terminology
The FACT-Hep is a 45-item, self-report instrument designed to measure HRQoL
in patients with HCC. The FACT-Hep consists of 27-item FACT-G, which assesses
generic HRQoL concerns using five subscales, and the newly validated
18-item hepatobiliary subscale, which assesses specific symptoms of hepatobiliary
cancer and side effects of treatment. The five FACT- Hep subscales are: (1)
physical well-being (7 questions); (2) social and family well-being (7 questions);
(3) emotional well-being (6 questions); and (4) functional well-being (7 questions);
and (5) hepatobiliary cancer subscale (20 questions).
Peer review
The paper quantifies the quality of life of 140 consecutive and unselected patients
with HCC. They have used the FACT-Hep questionnaire and classified
their patients according to TNM staging system.
REFERENCES
1 Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics,
2002. CA. Cancer J Clin 2005; 55: 74-108
2 Liu J, Fan D. Hepatitis B in China. Lancet 2007; 369: 1582-1583
3 Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E,
Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, Friedman C,
Harlan L, Warren J, Anderson RN, Pickle LW. Annual report
to the nation on the status of cancer, 1975-2002, featuring
population-based trends in cancer treatment. J Natl Cancer
Inst 2005; 97: 1407-1427
4 Geschwind JF, Ramsey DE, Choti MA, Thuluvath PJ,
Huncharek MS. Chemoembolization of hepatocellular carcinoma:
results of a metaanalysis. Am J Clin Oncol 2003; 26:
344-349
5 Lau WY, Lai EC. Hepatocellular carcinoma: current management
and recent advances. Hepatobiliary Pancreat Dis Int 2008;
7: 237-257
6 Llovet JM, Bruix J. Systematic review of randomized trials
for unresectable hepatocellular carcinoma: Chemoembolization
improves survival. Hepatology 2003; 37: 429-442
7 El-Serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis
and treatment of hepatocellular carcinoma. Gastroenterology
2008; 134: 1752-1763
8 Cahill BA, Braccia D. Current treatment for hepatocellular
carcinoma. Clin J Oncol Nurs 2004; 8: 393-399
9 Tuinman MA, Hoekstra HJ, Sleijfer DT, Fleer J, Vidrine DJ,
Gritz ER, Hoekstra-Weebers JE. Testicular cancer: a longitudinal
pilot study on stress response symptoms and quality of
life in couples before and after chemotherapy. Support Care
Cancer 2007; 15: 279-286
10 Ohara-Hirano Y, Kaku T, Hirakawa T, Noguchi Y, Hirata N,
Shinkoda H, Kitahara E, Saito T, Amada S, Ohki M. Uterine
cervical cancer: a holistic approach to mental health and it’s
socio-psychological implications. Fukuoka Igaku Zasshi 2004;
95: 183-194
11 Heffernan N, Cella D, Webster K, Odom L, Martone M, Passik
S, Bookbinder M, Fong Y, Jarnagin W, Blumgart L. Measuring
health-related quality of life in patients with hepatobiliary
cancers: the functional assessment of cancer therapyhepatobiliary
questionnaire. J Clin Oncol 2002; 20: 2229-2239
12 Zhu ZC, Lang QB, Chen Z, Li DT, Ling CQ. [Evaluation of
Chinese version of the Functional Assessment of Cancer
Therapy-Hepatobiliary questionnaire]. Zhongxiyi Jiehe Xuebao
2008; 6: 341-345
13 Que HF, Chen HF, Xu JN, Liu S, Lu DM, Tang HJ. [Discussion
of relationship between quality of life and clinical effect
assessment of malignant tumor treated with traditional Chinese
medicine]. Zhongxiyi Jiehe Xuebao 2005; 3: 253-256
14 Steel J, Baum A, Carr B. Quality of life in patients diagnosed
with primary hepatocellular carcinoma: hepatic arterial
WJG|www.wjgnet.com
infusion of Cisplatin versus 90-Yttrium microspheres (Therasphere).
Psychooncology 2004; 13: 73-79
15 You J.[Significance and necessity of developing quality of
life questionnaire for cancer patients adapting to traditional
Chinese medicine]. Zhongxiyi Jiehe Xuebao 2006; 4: 473-477
16 Huang YH, Chen CH, Chang TT, Chen SC, Wang SY, Lee
HS, Lin PW, Huang GT, Sheu JC, Tsai HM, Lee PC, Chau
GY, Lui WY, Lee SD, Wu JC. Evaluation of predictive value
of CLIP, Okuda, TNM and JIS staging systems for hepatocellular
carcinoma patients undergoing surgery. J Gastroenterol
Hepatol 2005; 20: 765-771
17 Sobin LH, Gospodarowicz MK, Wittekind C. Editors. TNM
Classification of Malignant Tumors. 7th ed. Oxford: John
Wiley and Sons, 2009
18 Poon RT, Fan ST, Yu WC, Lam BK, Chan FY, Wong J. A prospective
longitudinal study of quality of life after resection
of hepatocellular carcinoma. Arch Surg 2001; 136: 693-699
19 Steel JL, Chopra K, Olek MC, Carr BI. Health-related quality
of life: Hepatocellular carcinoma, chronic liver disease, and
the general population. Qual Life Res 2007; 16: 203-215
20 Sun V, Ferrell B, Juarez G, Wagman LD, Yen Y, Chung V.
Symptom concerns and quality of life in hepatobiliary cancers.
Oncol Nurs Forum 2008; 35: E45-E52
21 Fielding R, Wong WS. Quality of life as a predictor of cancer
survival among Chinese liver and lung cancer patients. Eur J
Cancer 2007; 43: 1723-1730
22 Steel JL, Geller DA, Carr BI. Proxy ratings of health related
quality of life in patients with hepatocellular carcinoma.
Qual Life Res 2005; 14: 1025-1033
23 Lai HL, Lin SY, Yeh SH. [Exploring uncertainty, quality of
life and related factors in patients with liver cancer]. Huli Zazhi
2007; 54: 41-52
24 Wang YB, Chen MH, Yan K, Yang W, Dai Y, Yin SS. Quality
of life after radiofrequency ablation combined with
transcatheter arterial chemoembolization for hepatocellular
carcinoma: comparison with transcatheter arterial chemoembolization
alone. Qual Life Res 2007; 16: 389-397
25 Steel JL, Eton DT, Cella D, Olek MC, Carr BI. Clinically
meaningful changes in health-related quality of life in patients
diagnosed with hepatobiliary carcinoma. Ann Oncol
2006; 17: 304-312
26 Chung H, Kudo M, Takahashi S, Hagiwara S, Sakaguchi Y,
Inoue T, Minami Y, Ueshima K, Fukunaga T, Matsunaga T.
Comparison of three current staging systems for hepatocellular
carcinoma: Japan integrated staging score, new Barcelona
Clinic Liver Cancer staging classification, and Tokyo
score. J Gastroenterol Hepatol 2008; 23: 445-452
27 Teuber G, Schäfer A, Rimpel J, Paul K, Keicher C, Scheurlen
M, Zeuzem S, Kraus MR. Deterioration of health-related
quality of life and fatigue in patients with chronic hepatitis C:
Association with demographic factors, inflammatory activity,
and degree of fibrosis. J Hepatol 2008; 49: 923-929
28 Bonkovsky HL, Snow KK, Malet PF, Back-Madruga C, Fontana
RJ, Sterling RK, Kulig CC, Di Bisceglie AM, Morgan TR,
Dienstag JL, Ghany MG, Gretch DR. Health-related quality
of life in patients with chronic hepatitis C and advanced fibrosis.
J Hepatol 2007; 46: 420-431
29 Poupon RE, Chrétien Y, Chazouillères O, Poupon R, Chwalow
J. Quality of life in patients with primary biliary cirrhosis.
Hepatology 2004; 40: 489-494
30 Montali L, Tanaka A, Riva P, Takahashi H, Cocchi C, Ueno
Y, Miglioretti M, Takikawa H, Vecchio L, Frigerio A, Bianchi
I, Jorgensen R, Lindor KD, Podda M, Invernizzi P. A short
version of a HRQoL questionnaire for Italian and Japanese
patients with Primary Biliary Cirrhosis. Dig Liver Dis 2010;
42: 718-723
S- Editor Gou SX L- Editor Ma JY E- Editor Xiong L
2694 June 7, 2012|Volume 18|Issue 21|